The Olsalazine Sodium Capsules, cataloged under National Stock Number 6505-01-334-8775, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Celltech Pharmaceuticals, Inc.. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 4 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-334-8775 |
| Primary Part Number | NDC53014-0726-71 |
| Item Name | Olsalazine Sodium Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Celltech Pharmaceuticals, Inc. |
| Status | ACTIVE |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 100.000 |
| Active Medicament Medicinal Strength | 250.000 MILLIGRAMS OLSALAZINE SODIUM ACTIVE INGREDIENT |
| Total Primary Container Quantity | 12 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00013-0105-01 | Brett Corp (USA) |
| NDC53014-0726-71 PRIMARY | Celltech Pharmaceuticals, Inc. (USA) |
| Reference | Meaning |
|---|---|
| NDC00016-0105-01 | 5/9 Secondary reference Pharmacia Inc Pharmacia Laboratories Div |
| DIPENTUM | 5/9 Secondary reference Pharmacia Inc Pharmacia Laboratories Div |
| DIPENTUM CAPSULES | 5/9 Secondary reference Pharmacia Inc Pharmacia Laboratories Div |
| A91B013 | 5/1 Secondary reference Department of the Army U S Army Medical Material Agency Mcmr-Mmo-Sa |
NSN 6505-01-334-8775 is a Olsalazine Sodium Capsules, manufactured by Celltech Pharmaceuticals, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-334-8775 has 2 manufacturer part numbers on file: NDC00013-0105-01 (Brett Corp), NDC53014-0726-71 (Celltech Pharmaceuticals, Inc.).
Key specifications for NDC53014-0726-71: Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 100.000; Part Name Assigned by Controlling Agency: OLSALAZINE SODIUM CAPSULES 250MG 100S BT 12 BT PER PG; Active Medicament Medicinal Strength: 250.000 MILLIGRAMS OLSALAZINE SODIUM ACTIVE INGREDIENT. 4 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.